lithium
check NA levels 2x per week until therapeutic levels and then monthly
ED50
defined therapeutic response in 50% of the population
pharmacogenetics
the study of genetic factors that influence an individuals response to a specific drug
pharmacogenomics
the study of how genetics play a role in a persons response to drugs
(MAT) Medication assisted therapy
gold standard for treatment of opioid use disorder
MAT drugs
methadone, buprenorphine with or without naloxone, naltrexone
Methadone
full mu-opioid agonist. The binding at adequate doses can result in the reduction of heroin or other
opioid use by decreased craving and withdrawal from other opioids
methadone
schedule II, 5 days to reach steady state, no ceiling effect. higher risk of overdose compared to
buprenorphine
patients who may need lower dose of methadone
older than 60, use benzos, hx of cardiac arrhythmias, brady, QT prolongation, electrolyte
abnormalitiies, asthma, copd
methadone side effects
dizziness, sedation, light headedness, N/V, contipation, diaphoresis, hypotension, cns depression,
respiratory depression,
methadone
is recommended for pregnant patients with OUD
Buprenorphine
partial agonist at the mu receptor
buprenorphine
commonly combined with naloxone to reduce risk of medication misuse